KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Inventory Average (2018 - 2025)

Ionis Pharmaceuticals has reported Inventory Average over the past 8 years, most recently at $10.3 million for Q4 2025.

  • Quarterly results put Inventory Average at $10.3 million for Q4 2025, down 49.91% from a year ago — trailing twelve months through Dec 2025 was $10.3 million (down 49.91% YoY), and the annual figure for FY2025 was $11.3 million, up 13.07%.
  • Inventory Average for Q4 2025 was $10.3 million at Ionis Pharmaceuticals, up from $9.5 million in the prior quarter.
  • Over the last five years, Inventory Average for IONS hit a ceiling of $29.5 million in Q2 2024 and a floor of $9.5 million in Q3 2025.
  • Median Inventory Average over the past 5 years was $22.0 million (2021), compared with a mean of $20.4 million.
  • Biggest five-year swings in Inventory Average: rose 26.49% in 2023 and later plummeted 66.85% in 2025.
  • Ionis Pharmaceuticals' Inventory Average stood at $23.9 million in 2021, then fell by 10.6% to $21.3 million in 2022, then dropped by 22.5% to $16.5 million in 2023, then grew by 23.85% to $20.5 million in 2024, then tumbled by 49.91% to $10.3 million in 2025.
  • The last three reported values for Inventory Average were $10.3 million (Q4 2025), $9.5 million (Q3 2025), and $10.0 million (Q2 2025) per Business Quant data.